Related by context. All words. (Click for frequent words.) 80 malignancies 78 prostate cancers 76 breast cancers 75 colorectal cancer 75 tumors 75 lung cancers 74 ovarian cancers 74 cancer 74 colorectal cancers 73 bladder cancers 72 lung cancer 71 pancreatic cancers 71 colon cancers 71 malignant tumors 70 melanoma 70 lymphomas 69 thyroid cancers 69 brain tumors 69 skin cancers 69 malignancy 69 colorectal cancer CRC 68 endometrial cancers 68 gastrointestinal cancers 68 prostate cancer 68 squamous cell carcinomas 68 ovarian tumors 68 bowel cancers 68 colon cancer 68 malignant melanoma 67 ovarian cancer 67 lung tumors 67 esophageal cancers 66 breast cancer 66 neuroendocrine tumors 66 testicular cancers 66 gastric cancer 66 gynecological cancers 66 gastric cancers 65 leukemias 65 oropharyngeal cancer 65 melanomas 65 breast tumors 65 rectal cancers 65 nonmelanoma skin cancers 65 basal cell carcinomas 65 metastatic cancer 65 diseases 64 liver cancer 64 cervical cancers 64 leukaemias 64 Cancers 64 carcinomas 64 squamous cell carcinoma 64 gliomas 64 lymphoma 64 squamous cell 63 adenocarcinoma 63 squamous cell cancer 63 metastatic disease 63 bladder cancer 63 squamous cell cancers 63 cancerdefine 63 endometrial cancer 63 prostate tumors 63 cervical cancer 63 colorectal tumors 63 metastases 62 oesophageal cancer 62 glioblastoma 62 pre cancerous lesions 62 prostate breast 62 prostate pancreatic 62 epithelial cancers 62 bowel cancer 62 precursor lesions 62 metastatic cancers 62 HPV infection 62 carcinoma 62 sarcomas 61 gynecologic cancers 61 soft tissue sarcomas 61 grade gliomas 61 solid tumors 61 pleural mesothelioma 61 ovarian lung 61 rectal cancer 61 precancerous lesions 61 prostate lung 61 breast endometrial 61 breast ovarian 61 uterine cancers 61 curable cancers 61 osteosarcomas 61 NSCLC 60 childhood leukemia 60 carcinoid cancer 60 serous ovarian cancer 60 cervical lesions 60 malignant growths 60 pancreatic tumors 60 disease 60 neuroblastomas 60 cardiovascular disease 60 pre cancerous growths 60 tumor 60 Esophageal cancer 60 cancerous tumors 60 anal cancers 60 mesotheliomas 60 molecular abnormalities 60 Colorectal cancer 60 Squamous cell 60 colorectal breast 60 brain metastases 60 GISTs 60 esophageal cancer 60 HPV infections 60 pancreatic adenocarcinoma 60 Basal cell carcinoma 60 Stomach cancer 60 pancreatic cancer 59 Basal cell 59 squamous cell carcinoma SCC 59 Melanomas 59 non Hodgkin lymphoma 59 cutaneous melanoma 59 malignant melanomas 59 renal cell carcinoma 59 invasive breast cancer 59 BRCA mutations 59 differentiated thyroid 59 systemic scleroderma 59 HER2 positive breast cancer 59 cell lymphomas 59 malignant pleural mesothelioma 59 Lung cancer 59 breast colon 59 medulloblastomas 59 epithelial tumors 59 metastasis 59 nonmelanoma skin cancer 59 sarcoma 59 Ovarian cancer 59 pre cancerous polyps 59 precancers 59 hereditary breast cancer 59 cell lung cancer 59 prostate cancer CaP 59 glioblastomas 59 heart disease 59 metastatic prostate cancer 59 medulloblastoma 59 hematological disorders 59 Prostate cancer 59 breast prostate 59 colorectal lung 59 Oesophageal cancer 59 colorectal 59 lung colorectal 59 neoplasms 59 multiple myeloma 59 basal cell 58 HPV 58 neuroendocrine cancers 58 prostrate cancer 58 lung prostate 58 lung diseases 58 Glioblastoma 58 angiosarcoma 58 skeletal metastases 58 renal cell carcinomas 58 MGUS 58 Gastric cancer 58 Malignant melanoma 58 ductal cancer 58 metastatic 58 colon breast 58 adenocarcinomas 58 HNSCC 58 Non Hodgkin lymphoma 58 pancreatic lung 58 lobular carcinoma 58 benign growths 58 GBM tumors 58 follicular lymphoma 58 cardiovascular diseases 58 lobular cancer 58 ductal breast cancer 58 metastatic colon cancer 58 gynecologic malignancy 58 basal cell cancer 58 ovarian pancreatic 58 lobular breast cancer 58 Acute lymphoblastic leukemia 58 cervical carcinoma 58 Gliomas 58 penile cancers 58 carcinoid tumors 58 thyroid cancer 58 lung pancreatic 58 medullary thyroid cancer 58 adenomatous polyps 58 basal cell carcinoma 58 Melanoma 58 chlamydial infection 58 invasive cervical cancer 58 carcinoid 58 basal cell cancers 57 lung adenocarcinoma 57 metastatic tumors 57 bone metastasis 57 Cervical cancer 57 prostate adenocarcinoma 57 Testicular cancer 57 Squamous cell carcinomas 57 basal cell nevus syndrome 57 nonsmall cell lung cancer 57 anaplastic 57 basal cell carcinoma BCC 57 premalignant lesions 57 cardio vascular disease 57 leukemia 57 seminoma 57 adenomas 57 non Hodgkin lymphomas 57 chromosomal abnormalities 57 malignant mesothelioma 57 metastatic colorectal 57 hepatocellular carcinoma 57 gene mutations 57 melanoma skin 57 colorectal polyps 57 Non Hodgkins lymphoma 57 Bladder cancer 57 ovarian breast 57 postmenopausal breast cancer 57 genetic mutations 57 chronic diseases 57 HCV infection 57 untreated celiac disease 57 neuroblastoma 57 esophageal adenocarcinoma 57 Colorectal cancers 57 Wilms tumor 57 laryngeal cancer 57 neoplasia 57 Cholangiocarcinoma 57 gynecologic cancer 57 familial pancreatic cancer 57 pre malignant lesions 57 renal carcinoma 57 cell carcinoma 57 genetic abnormalities 57 premalignant 57 uveal melanoma 57 neoplasias 57 HCV infections 56 colon tumors 56 PCNSL 56 atypical hyperplasia 56 hereditary predisposition 56 testicular germ cell 56 pharyngeal cancer 56 intestinal polyps 56 breast carcinomas 56 lung cancer asbestosis 56 Thyroid cancer 56 respiratory viral infections 56 colon pancreas 56 H. pylori infection 56 oesophageal cancers 56 metastatic melanoma 56 colorectal gastric 56 malignant lymphoma 56 Tumours 56 Breast cancer 56 squamous cell lung cancer 56 metastatic colorectal cancer 56 distant metastasis 56 meningiomas 56 metastatic lesions 56 Acoustic neuromas 56 precancerous growths 56 squamous cell skin 56 breast pancreatic 56 HER2 positive cancers 56 oesophageal 56 Colorectal cancer CRC 56 thyroid nodules 56 nasopharyngeal carcinoma 56 hamartomas 56 mutated KRAS gene 56 endocrine tumors 56 p# mutations 56 Barrett esophagus 56 commonly mutated genes 56 advanced adenomas 56 Chronic lymphocytic leukemia 56 digestive tract cancers 56 glioma 56 uterine ovarian 56 Hepatocellular Carcinoma HCC 56 ependymoma 56 cancerous growths 56 metastatic breast cancer 56 endometrial hyperplasia 56 cisplatin resistant 56 HER2 positive 56 pre cancerous 55 infections 55 leukemias lymphomas 55 nodular melanoma 55 diseases afflicting 55 oesophageal adenocarcinoma 55 precancerous colon polyps 55 PTEN mutations 55 mutations 55 CLL 55 esophageal tumors 55 osteosarcoma 55 malignant brain 55 prostate cancer PCa 55 testicular tumors 55 HPVs 55 basal cell skin 55 hormonal therapies 55 grade serous ovarian 55 inflammatory bowel disease 55 tumor recurrence 55 acute myeloid leukemia AML 55 bladder tumors 55 NAFLD 55 pneumococcal strains 55 seminomas 55 ependymomas 55 Medullary thyroid cancer 55 distant metastases 55 hepatocellular carcinoma HCC 55 melanoma tumors 55 ccRCC 55 human papillomavirus HPV 55 Glioblastoma multiforme GBM 55 malignant gliomas 55 mammary cancers 55 BRCA1 mutations 55 gum disease 55 thyroid tumors 55 cancerous lesions 55 Sjögren syndrome 55 benign polyps 55 Glioblastomas 55 childhood leukemias 55 Bowel cancer 55 brain tumor glioblastoma multiforme 55 Epstein Barr virus 55 acute lymphoid leukemia 55 HPV# 55 nasopharyngeal cancer 55 colon pancreatic 55 invasive ductal 55 Pancreatic neuroendocrine tumors 55 colorectal adenomas 55 Basal cell carcinomas 55 BRAF gene 55 breast cancer susceptibility genes 55 bowel polyps 55 Malignant mesothelioma 55 periodontitis 55 Pancreatic cancer 55 lymphatic tissue 55 PCa 55 GIST tumors 55 Follicular lymphoma 55 lung carcinomas 55 BRCA deficient 55 tumor cells 55 Brain metastases 55 cervical breast 55 autoimmune diseases 55 Basal Cell 55 Metastatic melanoma 55 colorectal prostate 55 gastrointestinal GI cancers 55 gynecological malignancies 54 papillary thyroid cancer 54 pancreatic ovarian 54 glioblastoma multiforme GBM 54 Rectal cancer 54 abnormal growths 54 bile duct cancers 54 genetic aberrations 54 Malignant tumors 54 synovial sarcoma 54 papillary 54 Thyroid nodules 54 Endometrial cancer 54 precancer 54 pancreatic prostate 54 Tumors 54 tumor subtypes 54 myeloid leukemia 54 scleroderma 54 hematologic malignancies 54 adenoid cystic carcinoma 54 liver metastases 54 acute leukemias 54 colorectal carcinoma 54 EGFR mutations 54 oesophageal squamous cell carcinoma 54 ALCL 54 EGFR mutation 54 bacterial infections 54 pituitary adenomas 54 alveolar rhabdomyosarcoma 54 MYCN amplification 54 liver disease 54 nonmelanoma 54 gynecological cancer 54 Synovial sarcoma 54 Metastases 54 breast cancer metastasis 54 malignant neoplasms 54 mesothelioma 54 lung adenocarcinomas 54 pre cancerous cells 54 neuro degenerative disease 54 retinoblastoma 54 renal tumors 54 inflammatory bowel diseases 54 Helicobacter pylori infection 54 precancerous tumors 54 precancerous 54 Burkitt lymphoma 54 metastatic bladder 54 BRCA2 mutations 54 faulty BRCA genes 54 malignant lymphomas 54 leiomyosarcoma 54 prostate tumor 54 benign breast 54 medulloblastoma tumors 54 hematological diseases 54 Osteosarcoma 54 ductal adenocarcinoma 54 mutated genes 54 Uterine cancer 54 cutaneous squamous cell carcinoma 54 Carcinoma 54 Acute myeloid leukemia 54 incidentalomas 54 hepatocellular cancer 54 tumor suppressor genes 54 precancerous cervical lesions 54 breast carcinoma 54 carcinogenesis 54 invasive carcinoma 54 commercialize deforolimus 54 HPV types 54 vascular diseases 54 lupus 54 atherosclerosis 54 glioblastoma multiforme 54 benign tumors 54 astrocytomas 54 neuroendocrine carcinoma 54 gastric adenocarcinoma 54 lung colon 54 CMV infection 54 colon polyps 54 aerodigestive tract 54 myelomas 54 Periodontal disease 54 breast cancer recurrence 54 cancerous polyps 54 prostate ovarian 54 pulmonary metastases 54 colorectal polyp 54 hematologic disorders 54 lymphoma subtypes 54 liver fibrosis 54 atherosclerotic disease 54 premenopausal breast cancer 54 FGFR2 54 mammary tumors 54 gastrointestinal stromal tumor 54 Metastatic 54 cancerous cells 53 ovarian colon 53 oropharyngeal squamous cell carcinoma 53 colon prostate 53 ADPKD 53 metastatic lung cancer 53 metastatic kidney 53 de ath 53 uterine tumors 53 leukemia ALL 53 cholangiocarcinoma 53 lymphoproliferative disorders 53 uterine cancer 53 neuroblastoma tumors 53 S. aureus infections 53 pancreatic colon 53 Recurrences 53 peritoneal cancer 53 fibroadenomas 53 neoplasm 53 Krabbe Disease 53 mitochondrial disorders 53 genetic alterations 53 Renal cell carcinoma 53 lipid abnormalities 53 PARP inhibitors 53 chronic lymphocytic leukemia CLL 53 malignant neoplasm 53 gene variants 53 grade cervical intraepithelial 53 esophageal squamous cell carcinoma 53 mitochondrial mutations 53 indolent NHL 53 Uterine fibroids 53 endometrial tumors 53 testicular cancer 53 cirrhosis liver failure 53 node metastases 53 oropharyngeal cancers 53 DCIS 53 Peritoneal mesothelioma 53 EBV infection 53 gastrointestinal stromal tumors GISTs 53 colo rectal cancer 53 malignant lesions 53 grade glioma 53 EGFR inhibitors 53 Candida infection 53 epithelial ovarian 53 Autoimmune diseases 53 colon lung 53 pilocytic astrocytomas 53 CYT# potent vascular disrupting 53 Meningiomas 53 acute myelogenous leukemia AML 53 tumor metastases 53 adenoma 53 genital herpes infections 53 childhood sunburns 53 abnormal mammograms 53 histologies 53 Chlamydia infection 53 pancreatic 53 gene mutation 53 allergic diseases 53 immunological diseases 53 lobular carcinomas 53 XMRV infection 53 Epstein Barr virus EBV 53 embryonal rhabdomyosarcoma 53 endometrial ovarian 53 prostate colorectal 53 invasive ductal carcinoma 53 axillary lymph nodes 53 chronic periodontitis 53 oligodendrogliomas 53 malignant cells 53 breast uterine 53 acoustic neuromas 53 acute myeloid leukemia 53 cranial irradiation 53 metastatic melanomas 53 paragangliomas 53 ovarian endometrial 52 MMP inhibitors 52 metastatic prostate 52 sporadic ALS 52 superficial bladder cancer 52 diffuse gastric 52 colorectal bowel 52 gastric carcinoma 52 familial ALS 52 vulvar cancers 52 Li Fraumeni 52 operable breast cancer 52 polycythemia vera 52 AAT deficiency 52 familial adenomatous polyposis 52 anti angiogenic therapy 52 breast colorectal 52 commonest cancers 52 curability 52 choriocarcinoma 52 prostate colon 52 Genetic variants 52 Glioblastoma multiforme 52 Colon polyps 52 venous blood clots 52 chronic hepatitis 52 CaP 52 leukemia myeloma 52 recurrent glioblastoma multiforme GBM 52 liposarcoma 52 myeloproliferative diseases 52 breast cervical 52 micrometastases 52 chromosome aberrations 52 genomic alterations 52 Male pattern baldness 52 oncogenic HPV types 52 gastrointestinal stromal tumors 52 Metastatic breast cancer 52 colon rectal cancer 52 viral infections 52 carcinoid tumor 52 Burkitt Lymphoma 52 non hodgkin lymphoma 52 urothelial cancer 52 autoimmune disease 52 lymphocytic leukemia 52 lymph node metastases 52 recurrent ovarian cancer 52 leiomyomas 52 periodontal bacteria 52 genes BRCA1 52 Bacterial infection 52 germline mutations 52 myelodysplastic syndrome MDS 52 genetic syndromes 52 pediatric malignancies 52 trans retinoic acid 52 Glioblastoma Multiforme GBM 52 imatinib Gleevec 52 chromosomal aberrations 52 esophagus colon 52 cancerous polyp 52 fungal meningitis 52 proliferative diabetic retinopathy 52 colorectal adenoma 52 polyp recurrence 52 abnormal Pap smears 52 Papillary 52 Inflammatory bowel diseases 52 adenomatous polyp 52 PARP inhibition 52 ocular melanoma 52 primary biliary cirrhosis 52 susceptibility genes 52 keloids 52 Hepatocellular carcinoma 52 genetic determinants 52 lymphoblastic lymphoma 52 bone metastases 52 histological subtype 52 precancerous spots 52 Sarcomas 52 bronchogenic carcinoma 52 cervical precancers 52 frequently benign tumor 52 Human papillomavirus HPV 52 pancreatic bladder 52 elevated CRP 52 hematopoietic cancers 52 peritoneal carcinomatosis 52 Alessandro Riva 52 atherosclerotic lesions 52 Gorlin syndrome 52 anal lesions 52 circulatory diseases 52 mycosis fungoides 52 Epithelial ovarian cancer 52 disease NAFLD 52 illnesses 52 myeloproliferative neoplasms 52 Adjuvant chemotherapy 52 rheumatic disease 52 malignant transformation 52 BCCs 52 radiosensitive 52 Staphylococcus aureus infections 52 noncancerous tumors 52 advanced adenoma 52 epigenetic changes 52 ovarian carcinoma 52 chronic lymphocytic leukemia 52 HbF 52 endometrial carcinoma 52 RET PTC rearrangements 52 Chronic myeloid leukemia CML 52 EGFR 52 HER2 overexpression 52 ductal carcinomas 52 estrogen receptor negative 52 carcinoma HNSCC 52 prostate carcinomas 52 overexpress HER2 52 prognostic indicator 52 hormone refractory prostate 52 Hashimoto thyroiditis 52 liver scarring 52 elevated triglyceride levels 52 precancerous cells 51 pituitary tumors 51 tumor histology 51 epithelial ovarian cancer 51 sCJD 51 breast ovary 51 Hedgehog pathway 51 herpes simplex encephalitis 51 hormone gastrin 51 lymphoid tumors 51 metastatic HER2 positive 51 Seewaldt 51 atypical ductal hyperplasia 51 antigen PSA 51 cancer metastasizes 51 Human papilloma virus 51 polyps 51 TTR amyloidosis 51 olaparib 51 specific antigen 51 situ LCIS 51 mycobacterial infections 51 cisplatin chemotherapy 51 melanoma lesions 51 toxicities 51 lymphoblastic leukemia 51 inherited mutations 51 PKCi 51 malignant pancreatic 51 essential thrombocythemia 51 JAK mutations 51 subclinical hyperthyroidism 51 solar keratosis 51 mtDNA mutations 51 biliary cancer 51 Squamous cell carcinoma 51 hematological malignancies 51 chromosomal rearrangement 51 papillomas 51 hemorrhagic strokes 51 invasive ductal breast cancer 51 osteoporotic fractures 51 dietary acrylamide 51 urothelial carcinoma 51 metastatic malignant melanoma 51 cell carcinomas 51 histologic subtype 51 genetic disorders 51 Helicobacter pylori H. pylori 51 cervical intraepithelial neoplasia 51 chronic prostatitis 51 anemias 51 tyrosine kinase inhibitors 51 cardiac glycosides 51 proliferative disorders 51 neoplastic lesions 51 locoregional recurrence 51 invasive lobular 51 Peanut allergy 51 Pleural mesothelioma 51 Human Papilloma Virus 51 BRCA mutation carriers 51 colorectal pancreatic 51 sentinel nodes 51 systemic lupus erythematosus SLE 51 neurodegenerative disorder 51 hemangiomas 51 kidney disease 51 nonseminoma 51 lysosomal storage diseases 51 meningioma 51 molecular subtypes 51 precancerous polyps 51 Her2 51 metastatic ovarian cancer 51 aneuploidies 51 birth defects 51 Adenocarcinoma 51 metastatic basal cell 51 promoter hypermethylation 51 lung cancer mesothelioma 51 hematological cancers 51 liver metastasis 51 glioblastoma tumors 51 glioma rarer 51 eflornithine 51 cervical dysplasia 51 diabetes 51 lung cancer NSCLC 51 diagnose Alzheimer disease 51 chemopreventive agents 51 histological subtypes 51 Lymphoma 51 GBMs 51 lipomas 51 Chronic myeloid leukemia 51 IDH1 mutations 51 thromboembolic disease 51 cruciferous vegetables 51 DCIS lesions 51 chemo resistant 51 androgenetic alopecia 51 neuro endocrine tumors 51 hormonally sensitive 51 somatic mutations 51 chlamydial infections 51 Mitochondrial diseases 51 lung nodules 51 distal colon cancer 51 pulmonary metastasis 51 ovarian colorectal 51 BRAF mutation 51 malignant prostate 51 chemotherapy regimens 51 motor neuron diseases 51 staphylococcal infections 51 epithelial tissues 51 colorectal neoplasia 51 dentinal hypersensitivity 51 thymic carcinoma 51 colorectal ovarian 51 prostate bladder 51 kidney urologic 51 coronary disease 51 Pap smear screening 51 myeloma 51 nonalcoholic steatohepatitis NASH 51 CIN3 + 51 squamous 51 colorectal neoplasms 51 postoperative pathology 51 adjuvant therapy 51 metastatic lymph nodes 51 Alzheimers disease 51 MALT lymphoma 51 chemotherapeutic agents 51 adjuvant therapies 51 methylation markers 51 smoldering myeloma 51 Squamous 51 bacterial overgrowth 51 polycystic ovary syndrome PCOS 51 urinary bladder cancer 51 genetic variants 51 atopic disease 51 Malignant Melanoma 51 cetuximab Erbitux 51 noncancerous cells 51 mucosal lesions 51 BRCA mutation 51 myopathies 51 S. aureus infection 51 pancreatic colorectal 51 papillary renal cell carcinoma 51 pneumococcal infection 51 precancerous condition 51 Medulloblastoma 51 HER2 positive breast 51 Genital warts 51 biphosphonates 51 fibrosis 51 APOL1 51 Inflammatory breast cancer 51 acute lymphoblastic 51 macrovascular complications 51 Waldenstrom macroglobulinemia 51 aneuploidy 51 folate deficiency 51 GIST 51 gene BRCA2 51 abnormalities 51 herpes viruses 51 Carcinoid tumors 51 Inhaled anthrax 51 endostatin 51 BRCA genes 51 prostate cancer CRPC 51 cervical cancer genital warts 51 thyroid dysfunction 51 standard chemotherapy regimens 51 leukaemic stem cells 51 Tay Sachs thalassemia 51 autoinflammatory diseases 51 human papillomaviruses 51 oncogenes 51 pathogenic mutations 51 benign lesions 51 herpes infection 51 salinomycin 51 Velculescu 51 CIN3 51 Kaposi sarcoma 51 isothiocyanates 51 pancreatic gastric 51 BRAF mutations 50 Rhabdomyosarcoma 50 sarcosine 50 rhabdomyosarcoma 50 oncological diseases 50 PARP inhibitor 50 EGFR pathway 50 ALK mutations 50 prognostic markers 50 vitamin D synthesis 50 cerebral infarction 50 Human Papillomavirus 50 squamous carcinoma 50 mTOR inhibitors 50 aneuploid cells 50 Anaplastic 50 cardiotoxicity 50 neoplastic 50 metachronous 50 tumor progression 50 pneumococcal pneumonia 50 myelofibrosis polycythemia vera 50 liver cirrhosis 50 cardiovascular disease hypertension 50 colorectum 50 stem cells CSCs 50 cancerous nodules 50 lymphatic cancers 50 abnormal Pap tests 50 Leukemias 50 Toxicities 50 precancerous cervical 50 gastrointestinal infections 50 inherited neurodegenerative disorder 50 Polyps 50 opportunistic pathogens 50 anti angiogenic drugs 50 amyloid deposits 50 dysglycemia 50 polyps growths 50 P. aeruginosa infections 50 H. pylori 50 malignant polyps 50 lymph node enlargement 50 alkylating agents 50 recurrent metastatic 50 PNET 50 HER2 50 diabetic nephropathy 50 angiogenesis inhibitors 50 NF kB pathway 50 squamous cells 50 mutated BRAF gene 50 IKZF1 50 breast cancer subtypes 50 iron overload 50 metastatic gastric 50 Adenomas 50 myeloproliferative disorders 50 pre cancerous lesion 50 mitochondrial toxicity 50 anticancer drugs 50 Aortic aneurysms 50 pheochromocytomas 50 Hepatocellular carcinoma HCC 50 GBA mutations 50 heavily pretreated 50 hematologic cancers 50 vulvar cancer 50 genetic variations 50 abnormal cervical 50 prostate carcinoma 50 pneumonias 50 myelogenous leukemia 50 noncancer 50 mitochondrial dysfunction 50 cervical abnormalities 50 malignant pheochromocytoma 50 nasopharyngeal carcinoma NPC 50 Glioma 50 chondrosarcoma 50 herpesviruses 50 Barrett esophagus BE 50 degenerative diseases 50 pelvic malignancies 50 hypovitaminosis D 50 EGFR blockers 50 pediatric acute lymphoblastic 50 taxane therapy 50 hyperplastic 50 anthracyclines 50 micro calcifications 50 lymphomas leukemias 50 bladder ovarian 50 Wilms tumors 50 Sjogren syndrome 50 CMV disease 50 Lymphomas 50 Cancer 50 pancreatic NET 50 cervical uterine 50 prostate abnormalities 50 endometrial kidney 50 faulty BRCA2 gene 50 breast caner 50 ocular toxicity 50 degenerative neurological diseases 50 systemic lupus erythematosus